Blood-brain barrier permeability and tPA-mediated neurotoxicity.
Abu Fanne R, Nassar T, Yarovoi S, Rayan A, Lamensdorf I, Karakoveski M, Vadim P, Jammal M, Cines DB, Higazi AA.
Neuropharmacology. 2010 Jun;58(7):972-80. doi: 10.1016/j.neuropharm.2009.12.017. Epub 2010 Jan 6.
Divergent impacts of tocilizumab and colchicine in COVID-19-associated coagulopathy: the role of alpha-defensins.
Abdeen S, Abu-Fanne R, Bdeir K, Maraga E, Higazi M, Cines DB, Heyman SN, Higazi AA.
Br J Haematol. 2022 Feb;196(4):923-927. doi: 10.1111/bjh.17885. Epub 2021 Oct 27.
The Diagnostic Value of Human Neutrophilic Peptides 1-3 in Acute Pediatric Febrile Illness.
Kassem E, Shapira M, Sussan M, Mahamid L, Amsalem N, Abu Fanne R.
J Clin Med. 2023 Oct 13;12(20):6514. doi: 10.3390/jcm12206514.
Performance and operational feasibility of antigen and antibody rapid diagnostic tests for COVID-19 in symptomatic and asymptomatic patients in Cameroon: a clinical, prospective, diagnostic accuracy study.
Boum Y, Fai KN, Nikolay B, Mboringong AB, Bebell LM, Ndifon M, Abbah A, Essaka R, Eteki L, Luquero F, Langendorf C, Mbarga NF, Essomba RG, Buri BD, Corine TM, Kameni BT, Mandeng N, Fanne M, Bisseck AZ, Ndongmo CB, Eyangoh S, Hamadou A, Ouamba JP, Koku MT, Njouom R, Claire OM, Esso L, Epée E, Mballa GAE.
Lancet Infect Dis. 2021 Aug;21(8):1089-1096. doi: 10.1016/S1473-3099(21)00132-8. Epub 2021 Mar 25.
Effect of CYP2C19 Pharmacogenetic Testing on Predicting Citalopram and Escitalopram Tolerability and Efficacy: A Retrospective, Longitudinal Cohort Study.
Mahajna M, Abu Fanne R, Berkovitch M, Tannous E, Vinker S, Green I, Matok I.
Biomedicines. 2023 Dec 7;11(12):3245. doi: 10.3390/biomedicines11123245.
The imprecision of measuring activated clotting time (ACT) from the guiding catheter during percutaneous coronary interventions.
Pollak AY, Kobo OM, Margolis G, Saada M, Sanchez-Jimenez E, Fanne RA, Levi Y, Barel M, Abu-Akel A, Roguin A.
Cardiovasc Revasc Med. 2024 May 6:S1553-8389(24)00464-0. doi: 10.1016/j.carrev.2024.05.006. Online ahead of print.
Influence of cytochrome P450 2D6*10/*10 genotype on the risk for tramadol associated adverse effects: a retrospective cohort study.
Mahajna M, Abu Fanne R, Odeh M, Berkovitch M, Tannous E, Eyal S, Vinker S, Green I, Matok I.
Front Pharmacol. 2024 Feb 19;15:1358549. doi: 10.3389/fphar.2024.1358549. eCollection 2024.
Effects of estradiol and raloxifene on arterial thrombosis in ovariectomized mice.
Abu-Fanne R, Brzezinski A, Golomb M, Grad E, Foldes AJ, Shufaro Y, Varon D, Brill A, Lotan C, Danenberg HD.
Menopause. 2008 Jan-Feb;15(1):98-104. doi: 10.1097/gme.0b013e318054e2ab.
